精优药业(00858.HK)：完成根据一般授权发行合共1.6亿股

Group 1 - The core announcement is that Jingyou Pharmaceutical (00858.HK) has fulfilled all the conditions precedent outlined in Subscription Agreement I, II, and III, leading to the completion of these agreements on September 10, 2025 [1] - A total of 160 million new shares have been issued on the same date at a subscription price of HKD 0.097 per share [1]